Data as of Apr 17
| +0.07 / +1.57%|
The 1 analysts offering 12-month price forecasts for SciClone Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +76.21% increase from the last price of 4.54.
The current consensus among 1 polled investment analysts is to Buy stock in SciClone Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.